Company news

Collegium Pharmaceutical, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Collegium Reports Second Quarter 2024 Financial Results

August 7, 2024

Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology

July 28, 2024

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

July 24, 2024

Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise

June 12, 2024

Collegium to Participate in Jefferies Global Healthcare Conference

May 28, 2024

Collegium Announces $35 Million Accelerated Share Repurchase Program

May 12, 2024

Collegium Reports First Quarter 2024 Financial Results

May 8, 2024

Collegium Announces CEO Transition

May 8, 2024

Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER

April 28, 2024

Collegium to Report First Quarter 2024 Financial Results on May 9, 2024

April 24, 2024

Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026

April 10, 2024

Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference

April 2, 2024

Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results

February 21, 2024

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024

February 7, 2024

Collegium Provides 2024 Financial Guidance

January 2, 2024

Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent

November 26, 2023

Collegium Reports Third Quarter 2023 Financial Results

November 6, 2023

Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023

October 23, 2023

Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023

August 27, 2023

Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026

August 23, 2023

Collegium Announces $50 Million Accelerated Share Repurchase Program

August 6, 2023

Collegium Reports Record 1H’23 Net Revenue of $280.3 Million, Up 35% Year-over-Year

August 2, 2023

Collegium to Report Second Quarter 2023 Financial Results on August 3, 2023

July 19, 2023

Collegium to Participate in Jefferies Healthcare Conference

May 31, 2023

Collegium Reports First Quarter 2023 Financial Results

May 3, 2023

Collegium to Report First Quarter 2023 Financial Results on May 4, 2023

April 19, 2023

Collegium to Participate in 22nd Annual Needham Virtual Healthcare Conference

April 10, 2023

Collegium Reports Fourth Quarter and Full-Year 2022 Financial Results

February 22, 2023

Collegium Pharmaceutical, Inc. Prices Upsized $210.0 Million Convertible Senior Notes Offering

February 6, 2023

Collegium Pharmaceutical, Inc. Announces Proposed Convertible Senior Notes Offering

February 5, 2023

Collegium Announces Fourth Quarter and Full Year 2022 Preliminary Financial Results

February 5, 2023

Collegium Provides 2023 Financial Guidance

January 3, 2023

Appeals Court Affirms Validity of Collegium’s Belbuca® Patents

December 21, 2022

Collegium to Participate in Piper Sandler 34th Annual Healthcare Conference

November 21, 2022

Collegium Reports Third Quarter 2022 Financial Results

November 2, 2022

Collegium to Report Third Quarter 2022 Financial Results on November 3, 2022

October 19, 2022

Collegium Announces 11 Poster Presentations at PAINWeek 2022 National Conference

August 29, 2022

Collegium Reports Second Quarter 2022 Financial Results

August 3, 2022

Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022

July 20, 2022

Collegium to Participate in H.C. Wainwright Global Investment Conference

May 16, 2022

Collegium Reports First Quarter 2022 Financial Results

May 9, 2022

Collegium to Host Conference Call to Discuss First Quarter 2022 Financial Results

April 25, 2022

Collegium to Participate in Upcoming Needham Healthcare Conference

April 6, 2022

Collegium Appoints Neil McFarlane to its Board of Directors

April 5, 2022

Collegium Provides 2022 Financial Guidance

April 4, 2022

Collegium Announces Master Settlement Agreement Resolving Pending Opioid-Related Litigation

March 29, 2022

Collegium Completes the Acquisition of BDSI

March 21, 2022

Collegium Reports Fourth Quarter and Full-Year 2021 Financial Results

February 23, 2022

Collegium to Acquire BioDelivery Sciences Broadening Pain Portfolio

February 13, 2022

Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2021 Financial Results

February 9, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 31 calls. Every call is listed under its year.

Decks

The 5 newest of 36 decks. Every deck is listed under its year.